| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/2009 | US20090239930 Therapeutic compounds |
| 09/24/2009 | US20090239929 N-Pyrrolidin-3-YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors |
| 09/24/2009 | US20090239928 N-Pyrrolidin-3YL-Amide Derivatives As Serotonin and Noradrenalin Re-Uptake Inhibitors |
| 09/24/2009 | US20090239927 Statin and Omega-3 Fatty Acids For Lipid Therapy |
| 09/24/2009 | US20090239926 Methods for the treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-carboxamide |
| 09/24/2009 | US20090239925 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators |
| 09/24/2009 | US20090239924 1h-furo[3,2-c]pyrazole compounds useful as kinase inhibitors |
| 09/24/2009 | US20090239923 Concentrated aqueous and/or ethanolic solution of 4-methylpyrazole (fomepizole) |
| 09/24/2009 | US20090239922 Kinesin inhibitors as cancer therapeutics |
| 09/24/2009 | US20090239921 Methods for treating neoplasms with derivatives of 4,5,6,7-tetrabromobenzimidazole |
| 09/24/2009 | US20090239920 Pharmaceutical formulations of an anhydrate crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 09/24/2009 | US20090239919 Glutamate receptor modulators and therapeutic agents |
| 09/24/2009 | US20090239918 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 09/24/2009 | US20090239917 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them |
| 09/24/2009 | US20090239916 Novel drug discovery target and medicine acting on the same |
| 09/24/2009 | US20090239915 Substituted 2-phenyl-benzimidazoles and their use as pharmaceuticals |
| 09/24/2009 | US20090239914 Phosphorus binder for treatment of renal disease |
| 09/24/2009 | US20090239913 Process for the treatment and prevention of diseases caused by fungi |
| 09/24/2009 | US20090239912 Concentrated, non-foaming solution of quaternary ammonium compounds and methods of use |
| 09/24/2009 | US20090239911 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 09/24/2009 | US20090239910 Benzenesulfonamide Compounds and Their Use |
| 09/24/2009 | US20090239909 Treatment of metabolic syndrome with lactams |
| 09/24/2009 | US20090239908 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 09/24/2009 | US20090239907 Methods and compositions for treating fish diseases |
| 09/24/2009 | US20090239905 Piperidines and related compounds for the treatment of dementia |
| 09/24/2009 | US20090239904 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 09/24/2009 | US20090239903 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/24/2009 | US20090239902 Quinine dosage forms and methods of use thereof |
| 09/24/2009 | US20090239901 Method and compositions for treatment of cerebral malaria |
| 09/24/2009 | US20090239900 Quinine and quinidine salts, methods for making them, and pharmaceutical formulations comprising them |
| 09/24/2009 | US20090239899 Triazolopyridinylsulfanyl Derivatives As P38 Map Kinase Inhibitors |
| 09/24/2009 | US20090239898 Further therapeutic use of zolpidem |
| 09/24/2009 | US20090239897 Novel compounds |
| 09/24/2009 | US20090239896 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 09/24/2009 | US20090239895 Novel 3-thia-10-aza-phenanthrene derivatives |
| 09/24/2009 | US20090239894 Stabilized aqueous solutions of ergoline compounds |
| 09/24/2009 | US20090239893 Synthesis of gimatecan by reacting an acetal of 7-formyl-camptothecin with O-t-butylhydroxylamine hydrochloride in a polar protic or aprotic organic solvent |
| 09/24/2009 | US20090239892 Pyridomorphinans, pyridazinomorphinans and use thereof |
| 09/24/2009 | US20090239891 Sustained Release Dosage Forms of Analgesic Medications |
| 09/24/2009 | US20090239890 Spiro substituted cyclopropane compounds for the treatment of inflammatory disorders |
| 09/24/2009 | US20090239889 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents |
| 09/24/2009 | US20090239888 Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation |
| 09/24/2009 | US20090239887 Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
| 09/24/2009 | US20090239886 Substituted xanthine derivatives |
| 09/24/2009 | US20090239885 Inhibitors of nucleoside phoshorylases and nucleosidases |
| 09/24/2009 | US20090239884 Methods of Treating Inflammation |
| 09/24/2009 | US20090239883 Treatment of Pulmonary Hypertension |
| 09/24/2009 | US20090239882 Thiazolopyramidine Compounds for the Modulation of Chemokine Receptor Activity |
| 09/24/2009 | US20090239881 Combinations of Flibanserin with Caffeine, Process for Their Preparation and Use Thereof as Medicaments |
| 09/24/2009 | US20090239880 Combinations of monoamine reuptake inhibitors and potassium channel activators |
| 09/24/2009 | US20090239879 N-oxides of n-phenyl-2-pyrimidine-amine derivatives |
| 09/24/2009 | US20090239878 Combinations of (a) an atp-competitive inhibitor of c-abl kinase activity with (b) two or more other antineoplastic agents |
| 09/24/2009 | US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | US20090239876 Substituted 4-Hydroxypyrimidine-5-Carboxamides |
| 09/24/2009 | US20090239875 Protection of ferulic acid and/or tetramethylpyrazine against retinal ischaemia, glaucoma and siderosis oculi |
| 09/24/2009 | US20090239874 Pyrido[3,2-e]pyrazines, their use as inhibitors of phospohodiesterase 10, and processes for preparing them |
| 09/24/2009 | US20090239873 Phenyl-piperazine derivatives as modulators of muscarinic receptors |
| 09/24/2009 | US20090239872 Treatment of mesothelioma |
| 09/24/2009 | US20090239871 antitumor; breast cancer; 8,9-Dimethoxy-2,3-methylenedioxy-5-[2-(N,N-dimethylamino)ethyl]-5H-dibenzo[c,h]1,6-naphthyridin-6-one |
| 09/24/2009 | US20090239870 Spirohydantoin Aryl Cgrp Receptor Antagonists |
| 09/24/2009 | US20090239869 Therapeutic substituted cyclopentanes |
| 09/24/2009 | US20090239868 Inhibitor of pai-1 production |
| 09/24/2009 | US20090239867 1-(2,4-Dimethoxybenzyl)-5-oxo-pyrrolidine-3-carboxylic Acid Methyl Ester; for treating inflammatory bowel disease, glaucoma or ocular hypertension, asthma or baldness; prostaglandin EP2 agonists |
| 09/24/2009 | US20090239866 Peptide deformylase inhibitors |
| 09/24/2009 | US20090239865 Dibenzyl amine compounds and derivatives |
| 09/24/2009 | US20090239864 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
| 09/24/2009 | US20090239863 1-aryl-or 1- alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 09/24/2009 | US20090239862 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 09/24/2009 | US20090239861 Quinazoline derivatives as anticancer agents |
| 09/24/2009 | US20090239860 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 09/24/2009 | US20090239859 Protein kinase modulators |
| 09/24/2009 | US20090239858 Therapeutic amides |
| 09/24/2009 | US20090239857 Triamine derivative |
| 09/24/2009 | US20090239856 Use of Pyrrolopyridine Compounds for Activating PPAR Receptors and Treatment of Conditions Involving Such Receptors |
| 09/24/2009 | US20090239855 Rapamycin Analogues and the Uses Thereof in the Treatment of Neurological, Proliferative, and Inflammatory Disorders |
| 09/24/2009 | US20090239854 Tetracyclic compounds |
| 09/24/2009 | US20090239853 Fused heterocycle derivative |
| 09/24/2009 | US20090239852 Use of oxicam compounds |
| 09/24/2009 | US20090239851 Benzothiazinone Derivatives and their Use as Antibacterial Agents |
| 09/24/2009 | US20090239850 Kinase protein binding inhibitors |
| 09/24/2009 | US20090239849 Aryl-Fused Spirocyclic Compounds |
| 09/24/2009 | US20090239848 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239847 Organic compounds |
| 09/24/2009 | US20090239846 Novel Compounds |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | US20090239844 Ace inhibitor-vasopressin antagonist combinations |
| 09/24/2009 | US20090239843 Bridged diazepan orexin receptor antagonists |
| 09/24/2009 | US20090239842 Solutions containing epinastin |
| 09/24/2009 | US20090239841 Diaryl Ureas as CB1 Antagonists |
| 09/24/2009 | US20090239840 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239838 Pyrrolotriazine kinase inhibitors |
| 09/24/2009 | US20090239837 Cholesterol-producing yeast strains and uses thereof |
| 09/24/2009 | US20090239836 Multifunctional Ophthalmic Compositions |
| 09/24/2009 | US20090239835 Stabilization of glucocorticoid esters with acids |
| 09/24/2009 | US20090239834 Mcc-257 modulation of neurogenesis |
| 09/24/2009 | US20090239833 Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application |
| 09/24/2009 | US20090239832 Drugs for chronic pain |
| 09/24/2009 | US20090239831 Compositions and methods for reducing hepatotoxicity associated with drug administration and treating non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and associated cirrhosis |
| 09/24/2009 | US20090239830 Treatment of viral infections by modulation of host cell metabolic pathways |